Literature DB >> 16574268

Cartilage tissue engineering for degenerative joint disease.

Dobrila Nesic1, Robert Whiteside, Mats Brittberg, David Wendt, Ivan Martin, Pierre Mainil-Varlet.   

Abstract

Pain in the joint is often due to cartilage degeneration and represents a serious medical problem affecting people of all ages. Although many, mostly surgical techniques, are currently employed to treat cartilage lesions, none has given satisfactory results in the long term. Recent advances in biology and material science have brought tissue engineering to the forefront of new cartilage repair techniques. The combination of autologous cells, specifically designed scaffolds, bioreactors, mechanical stimulations and growth factors together with the knowledge that underlies the principles of cell biology offers promising avenues for cartilage tissue regeneration. The present review explores basic biology mechanisms for cartilage reconstruction and summarizes the advances in the tissue engineering approaches. Furthermore, the limits of the new methods and their potential application in the osteoarthritic conditions are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16574268     DOI: 10.1016/j.addr.2006.01.012

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  37 in total

1.  Elastin-like protein-hyaluronic acid (ELP-HA) hydrogels with decoupled mechanical and biochemical cues for cartilage regeneration.

Authors:  Danqing Zhu; Huiyuan Wang; Pavin Trinh; Sarah C Heilshorn; Fan Yang
Journal:  Biomaterials       Date:  2017-03-03       Impact factor: 12.479

2.  Mesenchymal stem cells and tissue engineering.

Authors:  Nicholas W Marion; Jeremy J Mao
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  Potential of 3-D tissue constructs engineered from bovine chondrocytes/silk fibroin-chitosan for in vitro cartilage tissue engineering.

Authors:  Nandana Bhardwaj; Quynhhoa T Nguyen; Albert C Chen; David L Kaplan; Robert L Sah; Subhas C Kundu
Journal:  Biomaterials       Date:  2011-05-20       Impact factor: 12.479

4.  Potential of Raloxifene in reversing osteoarthritis-like alterations in rat chondrocytes: an in vitro model study.

Authors:  Aysegul Kavas; Seda Tuncay Cagatay; Sreeparna Banerjee; Dilek Keskin; Aysen Tezcaner
Journal:  J Biosci       Date:  2013-03       Impact factor: 1.826

5.  Three-dimensional in vitro effects of compression and time in culture on aggregate modulus and on gene expression and protein content of collagen type II in murine chondrocytes.

Authors:  Kumar Chokalingam; Shawn Hunter; Cynthia Gooch; Chris Frede; Jane Florer; Richard Wenstrup; David Butler
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

6.  Low oxygen tension during incubation periods of chondrocyte expansion is sufficient to enhance postexpansion chondrogenesis.

Authors:  James H Henderson; Nell M Ginley; Arnold I Caplan; Christopher Niyibizi; James E Dennis
Journal:  Tissue Eng Part A       Date:  2010-05       Impact factor: 3.845

7.  The optimization of a scaffold for cartilage regeneration.

Authors:  Cristina Foss; Claudio Migliaresi; Antonella Motta
Journal:  Organogenesis       Date:  2013-01-01       Impact factor: 2.500

8.  Isolation, characterization, and differentiation of stem cells for cartilage regeneration.

Authors:  Olivia S Beane; Eric M Darling
Journal:  Ann Biomed Eng       Date:  2012-08-21       Impact factor: 3.934

9.  Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer.

Authors:  Andre F Steinert; Glyn D Palmer; Carmencita Pilapil; Ulrich Nöth; Christopher H Evans; Steven C Ghivizzani
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

10.  Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer.

Authors:  Andre F Steinert; Benedikt Proffen; Manuela Kunz; Christian Hendrich; Steven C Ghivizzani; Ulrich Nöth; Axel Rethwilm; Jochen Eulert; Christopher H Evans
Journal:  Arthritis Res Ther       Date:  2009-10-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.